E-LIB Suche - Ergebnisse für: Guardiola, J.

1

P1211 A faecal microbial signature, in combination with fae..:

Taboada-López, S ; Malagón, M ; Amoedo, J...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2155-i2155 , 2024

Link: https://doi.org/10.1093/..

2

DOP75 Frequency and effectiveness of dose escalation of bio..:

Rubín De Célix, C ; Ricart, E ; Martín-Arranz, M D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i211-i213 , 2024

Link: https://doi.org/10.1093/..

3

P817 Incidence and risk factors of infection in patients wi..:

Zabana, Y ; Rodríguez-Lago, I ; Sicilia, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1518-i1520 , 2024

Link: https://doi.org/10.1093/..

4

P419 Proximal Crohn's disease location is associated with a..:

Romero-Mascarell, C ; Giordano, A ; Riestra, S...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i865-i866 , 2024

Link: https://doi.org/10.1093/..

5

P569 Persistence and safety of upadacitinib in Crohn's dise..:

García, M J ; Brenes, Y ; Vicuña, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1112-i1113 , 2024

Link: https://doi.org/10.1093/..

6

P649 Long-term follow-up of the PROTDILAT study; LONG-PROTD..:

Ruiz Ramírez, P ; Loras, C ; Gornals, J...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1236-i1236 , 2024

Link: https://doi.org/10.1093/..

7

P844 Frequency and effectiveness of dose de-escalation of b..:

Rubín De Célix, C ; Ricart, E ; Martín-Arranz, M D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1567-i1569 , 2024

Link: https://doi.org/10.1093/..

8

P655 The ileorectal anastomosis after a total colectomy is ..:

Tapiolas, I ; Mañosa, M ; Troya, J...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1249-i1249 , 2024

Link: https://doi.org/10.1093/..

9

P989 Switching from intravenous to subcutaneous vedolizumab..:

Gros, B ; Manceñido Marcos, N ; Guardiola, J...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1793-i1795 , 2024

Link: https://doi.org/10.1093/..

10

P410 Long-term persistence and safety of biological drugs i..:

Gargallo-Puyuelo, C ; Ricard, E ; Iborra, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i539-i540 , 2023

Link: https://doi.org/10.1093/..

11

P-070 SARS-CoV2 antibody isotypes in seminal fluid of vacci..:

Schaler, L ; Ghanim, M ; Guardiola, J...
Human Reproduction. 38 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

12

P694 Long-term monitoring of post-surgical recurrence in Cr..:

Mañosa Ciria, M ; Oller, B ; Garcia-Planella, E...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i824-i825 , 2023

Link: https://doi.org/10.1093/..

13

P386 Clinical presentation, management, and evolution of ly..:

Guerra Marina, I ; Bujanda, L ; Mañosa, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i519-i520 , 2023

Link: https://doi.org/10.1093/..

14

P634 Ustekinumab and vedolizumab as first-line biological t..:

Calafat Sard, M ; Pascual, I ; Nos, P...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i766-i767 , 2023

Link: https://doi.org/10.1093/..

15

DOP73 A comparative efficacy and safety analysis of subcuta..:

Peyrin-Biroulet, L ; Arkkila, P ; Armuzzi, A...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i116-i117 , 2022

Link: https://doi.org/10.1093/..